₹25,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 3 Years
If you had started a ₹25,000/month SIP on 18 Aug 2023 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 37 installments.
You invested
₹9,25,000
37 installments
Value today
₹11,41,186
18 Aug 2026
Absolute gain
+₹2,16,186
+23.4%
XIRR (annualised)
14.08%
money-weighted
The journey, month by month
Worst fall on the way
-12.2%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
1
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹10,30,057
Modelled at historical FD rates. The fund beat FD by ₹1,11,129.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (19 Aug 2024) | ₹3,25,000 | ₹4,07,714 | +25.5% |
| Year 2 (18 Aug 2025) | ₹6,25,000 | ₹7,39,001 | +18.2% |
| Year 3 (18 Aug 2026) | ₹9,25,000 | ₹11,41,186 | +23.4% |
Best year of the journey: Year 1 (+25.5% market move) · Toughest year: Year 2 (4.4%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 18 Aug 2023 and 18 Aug 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.